PAX3–FOXO1 fusion gene in rhabdomyosarcoma
- 18 October 2008
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 270 (1), 10-18
- https://doi.org/10.1016/j.canlet.2008.03.035
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcomaBiochemical and Biophysical Research Communications, 2008
- PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1Proceedings of the National Academy of Sciences of the United States of America, 2007
- The PAX3-FKHR Fusion Gene of Rhabdomyosarcoma Cooperates with Loss of p16INK4A to Promote Bypass of Cellular SenescenceCancer Research, 2007
- Global gene expression profiling of PAX‐FKHR fusion‐positive alveolar and PAX‐FKHR fusion‐negative embryonal rhabdomyosarcomasThe Journal of Pathology, 2007
- Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial: A Report from the Children's Oncology GroupThe Journal of Molecular Diagnostics, 2006
- Gene expression profiling identifies potential relevant genes in alveolar rhabdomyosarcoma pathogenesis and discriminates PAX3‐FKHR positive and negative tumorsInternational Journal of Cancer, 2006
- PAX3-FKHR Transformation Increases 26 S Proteasome-dependent Degradation of p27Kip1, a Potential Role for Elevated Skp2 ExpressionPublished by Elsevier BV ,2003
- Preferential Binding of Grb2 or Phosphatidylinositol 3-Kinase to the Met Receptor Has Opposite Effects on HGF-Induced Myoblast ProliferationExperimental Cell Research, 2002
- Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?British Journal of Cancer, 2001
- The Hallmarks of CancerCell, 2000